NCT02397590 Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02374047 A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02370784 Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma Status COMPLETED Phase PHASE2
NCT02364258 Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients Status COMPLETED Phase PHASE1
NCT02355704 Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney Status COMPLETED Phase PHASE3
NCT02286544 Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02260648 A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT02254824 Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients Status UNKNOWN Phase PHASE4
NCT02245269 Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02243098 Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02227784 A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Status TERMINATED Phase PHASE3
NCT02205775 Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty Status TERMINATED Phase PHASE3
NCT02197065 Pilot Study of Atorvastatin for Orthopedic Surgery Patients Status COMPLETED Phase PHASE2
NCT02192320 The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders Status UNKNOWN Phase PHASE2
NCT02189837 Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody Status COMPLETED Phase PHASE3